The goals of this conference are to:

1. Bring together distinguished experts, leading scientists, and trainees in this burgeoning field to discuss ground-breaking discoveries, transformative new concepts, and promising technologies that have the potential to usher new paths to therapeutic intervention. 
2. Stimulate collaboration between groups working on elucidating biochemical aspects of TME biology at the cellular and molecular levels with groups that are engaged in drug discovery, development of innovative imaging modalities or are engaged in oncology clinical trials.
3. Critically evaluate state-of-the-art imaging and treatment modalities (including immune-radiotherapy) that harness features of the TME to enhance anti-tumor responses and shape the future of personalized cancer care.
4. Share recently published or unpublished research findings, engage in lively discussions, and forge connections with experts from diverse backgrounds in the TME and more broadly, the oncology field.
5. Receive constructive feedback, develop new collaborations and network with some of the best minds in the field in a collegial and interactive scientific environment.

Highlights of the Conference include:

✓ Engaging keynote lectures by renowned scientists, sharing their groundbreaking discoveries.

✓ Insightful panel discussions on the challenges and opportunities in targeting the tumor microenvironment.

✓ Dedicated time for poster sessions showcasing cutting-edge research and fostering interactive discussions.

✓ Networking opportunities to connect with global thought leaders, fellow researchers, trainees, industry leaders, scientific journal editors and NIH officials.

✓ Visits to cultural treasures of Paphos and Cyprus from ancient antiquity to recent times.

Who Should Attend?

This meeting is designed for scientists, clinicians, researchers, and students passionate about understanding and overcoming treatment resistance in cancer. Whether you’re an early-career researcher or an established expert, this event offers a platform to expand your knowledge, collaborate, and contribute to the collective effort to combat cancer.

Past speakers at meetings put together by the scientific organizers (from 2009-2022) include:

Ravi Amaravadi-UPenn, Gabrielle Bergers-UCSF/Leuven, Rob Bristow-Manchester, Lisa Coussens-UOHSU, Gerard Evan-Cambridge, Doug Green-St Jude’s, Steve Hahn-UPenn/MDACC (former FDA Commissioner), Marcia Haigis-Harvard, Linda Hendershot-St Jude’s, Elizabeth Jaffee-Johns Hopkins, Randy Johnson-Cambridge, Bill Kaelin-Harvard (2019 Nobel Laureate), Raghu Kalluri-MDACC, Yibin Kang-Princeton, Jan Karlseder-Salk Inst, Guido Kroemer-Univ. Paris, Quynh Le-Stanford, Amy Lee-USC, Jim Metz-UPenn, Vassilis Ntziachristos-Munich, Lorenz Poellinger-Karolinska, Jeffrey Pollard-Albert Einstein, Simon Powell-MSKCC, Peter Ratcliffe-Oxford (2019 Nobel Laureate), Davide Ruggero-UCSF, Ruth Scherz-Shouval-Weizmann, Celeste Simon-UPenn, Andrew Thorburn-Univ. of Colorado, Marie-Catherine Vozenin-Lausanne, Xiao-Fan Wang-Duke, Ashi Weeraratna-Johns Hopkins, Eileen White-NJCI, Brad Wouters-Toronto, and others.

Registration costs

The registration conference cost for established investigators is €1450, which includes attendance to all scientific portions of the meeting, 5* hotel accommodation for 5 nights, all meals at the hotel/local taverns, local transportation and a city tour. It is the policy of the Cyprus TME Conference that all speakers must remain at the conference venue for all days. The usefulness of such conferences comes as much from informal discussions as from formal presentations. To encourage the participation of young scientists, the conference will be offering generous Trainee Travel Awards to offset a significant portion of the travel expenses. The recipients of these awards will be selected based on the scientific merit of submitted abstracts. Special daily registration pricing will be made available for a few local attendees and trainees who attend the scientific portion of the conference. Please inquire by emailing the organizers.

Notes for sponsors

The Conference welcomes sponsorships from established vendors, pharmaceutical companies, foundations, and institutions. Funds will be used to cover expenses of Keynote speakers (we anticipate 2-3 Nobel Laureates will be invited) and defray the cost of invited speakers. Moreover, funds raised will cover a substantial portion of travel and registration fees for trainees. Some of the most prominent scientists and clinicians in the field of oncology are expected to attend. An exhibit area is available to set up booths and interact with the attendees. The conference will be capped at 120-130 individuals, allowing for ample time to visit the exhibit areas and for discussions. Sponsors will be prominently featured on the Conference website, the scientific program and in rolling slides throughout the scientific portion of the meeting. Opportunities for named travel awards and Keynote lectures are provided. Finally, sponsors will be featured in any local media coverage of the event.

The sponsorships depending on the object are as follows (multiple sponsorships are welcome):

• Presence at the exhibition space with a stand/pavilion: €5,000
• Nobel Laureate Speaking Grant: €5,000
• Distinguished Professor Speaking Grant: €2,000
• Student/trainee presentation grant: €1,500
• Simple sponsorship with mention/logo in the program and on the conference website: €1,000

We look forward to your organization’s active support of this important conference. We believe that TMCS 2024 will contribute significantly to highlighting the serious scientific work being carried out in Cyprus, and to the promotion of opportunities for developing partnerships with the public and private sectors on the island.